Cardiovascular disease Circulatory System Cardiovascular disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Written informed consent given by participant. 2. Male or female patients aged 18 to 80 years inclusive. 3. Undergoing investigations for cardiovascular disease (CVD) 4. Is likely to have, or has had recent diagnostic investigations performed as part of routine clinical care relevant to diagnosis of CVD
Exclusion criteria
Exclusion criteria: 1. Any clinically significant medical condition or abnormality, which, in the opinion of the investigator, or cardiologist might compromise the safety of the patient 2. Females who are known to be pregnant or lactating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reliability of the device as measured by number of decipherable measurements produced during the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Correlation between device measurement and current diagnostic results 2. Correlation between follow up exacerbation rate and device measurement 3. Acceptability of device measurements as described by participant feedback scores and number of adverse device effects recorded | — |
Countries
United Kingdom